Blocking IL-1 signaling has been shown to rescue cognition and attenuate Tau pathology in an animal model of AD (Kitazawa et al., 2011), strongly suggesting that IL-1 contributes to the pathogenesis of AD. The gene discussed is MAPT; the disease is Alzheimer disease.